ATLAS / Macro Radar / Reporting / EWTX

Edgewise Therapeutics, Inc. (EWTX) reporting calendar

Edgewise Therapeutics, Inc. files periodic reports with the SEC as EWTX on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 19 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
21

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open EWTX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001104659-26-056713
10-K31 Dec 202526 Feb 202657 days0001104659-26-020112
10-Q30 Sep 20256 Nov 202537 days0001104659-25-107427
10-Q30 Jun 20257 Aug 202538 days0001558370-25-010655
10-Q31 Mar 20258 May 202538 days0001558370-25-006857
10-K31 Dec 20243 Mar 202562 days0001558370-25-002006
10-Q30 Sep 20247 Nov 202438 days0001558370-24-014762
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011477
10-Q31 Mar 20249 May 202439 days0001544784-24-000056
10-K31 Dec 202322 Feb 202453 days0001558370-24-001467
10-Q30 Sep 20239 Nov 202340 days0001558370-23-018427
10-Q30 Jun 202310 Aug 202341 days0001558370-23-014410
10-Q31 Mar 202311 May 202341 days0001558370-23-009268
10-K31 Dec 202223 Feb 202354 days0001558370-23-001895
10-Q30 Sep 20223 Nov 202234 days0001558370-22-016149
10-Q30 Jun 20224 Aug 202235 days0001558370-22-012067
10-Q31 Mar 202211 May 202241 days0001558370-22-008235
10-K31 Dec 202124 Feb 202255 days0001558370-22-001850
10-Q30 Sep 202110 Nov 202141 days0001558370-21-015395
10-Q30 Jun 20219 Aug 202140 days0001558370-21-010888
10-Q31 Mar 202113 May 202143 days0001558370-21-007088

Source: SEC EDGAR company submissions for CIK 0001710072. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.